Rockefeller Capital Management
ZEAL

Rockefeller Capital Management’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Rockefeller Capital Management’s Portfolio ZEAL Stock Details ZEAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,994
Closed -$175K – 2878
2020
Q2 		$175K Sell
4,994
-3,882
-44% -$138K ﹤0.01% 995
2020
Q1 		$306K Sell
8,876
-872
-9% -$30.4K ﹤0.01% 716
2019
Q4 		$324K Buy
+9,748
New +$291K ﹤0.01% 659

Other funds holding ZEAL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rockefeller Capital Management's ZEAL Position: Q3 2020 in Review

Rockefeller Capital Management sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2020, closing a stake of 4,994 shares — an estimated $175K sold.

Rockefeller Capital Management first reported a position in ZEAL in Q4 2019 and held it in 3 quarters. The position peaked at $324K in Q4 2019. 14 funds tracked by Wall St. Rank hold ZEAL as of Q3 2020.

  • Rockefeller Capital Management reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 4,994 Zealand Pharma A/S American Depositary Shares shares in Q3 2020, an estimated $175K.
  • Rockefeller Capital Management first reported a position in Zealand Pharma A/S American Depositary Shares in Q4 2019 and held it in 3 quarters.
  • Rockefeller Capital Management's Zealand Pharma A/S American Depositary Shares position peaked at $324K in Q4 2019.
  • 14 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2020.

Based on Rockefeller Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.